The effect of acori graminei Rhizoma and extract fractions on spatial memory and hippocampal neurogenesis in Amyloid Beta 1-42 injected mice

CNS and Neurological Disorders - Drug Targets

Volumn 14, Issue 3, 2015, Pages 411-420

  Ma, Yuxin ^a   Tian, Sumin ^a   Sun, Lingzhi ^a   Yao, Shizhang ^a   Liang, Zihao ^a   Li, Shanshan ^a   Liu, Jing ^a   Zang, Linquan ^a   Li, Guoying ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Acori graminei rhizoma; Alzheimer disease; Amyloid beta; Doublecortin; Extract fraction; Nestin

Indexed keywords

ACORI GRAMINEI RHIZOME EXTRACT; AMYLOID BETA PROTEIN [1-42]; DOUBLECORTIN; NESTIN; PLANT EXTRACT; UNCLASSIFIED DRUG; ACORI GRAMINEI RHIZOMA; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); DOUBLECORTIN PROTEIN; ESSENTIAL OIL; HERBACEOUS AGENT; MICROTUBULE ASSOCIATED PROTEIN; NES PROTEIN, MOUSE; NEUROPEPTIDE; NOOTROPIC AGENT; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MORRIS WATER MAZE TEST; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PROTEIN EXPRESSION; SPATIAL MEMORY; WESTERN BLOTTING; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECTS; MAZE TEST; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PHYTOTHERAPY; RANDOMIZATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; HIPPOCAMPUS; MALE; MAZE LEARNING; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NESTIN; NEUROGENESIS; NEUROPEPTIDES; NOOTROPIC AGENTS; OILS, VOLATILE; PEPTIDE FRAGMENTS; PHYTOTHERAPY; PLANT EXTRACTS; RANDOM ALLOCATION; SPATIAL MEMORY;

EID: 84929232319     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527314666150225124348     Document Type: Article

References (34)

1. Kurinami H, Sato N, Shinohara M, et al. Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse model. Int J Mol Med 2008; 21: 531.
2. Ali SK, Hamed AR, Soltan MM, et al. In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of alzheimer disease. BMC Complement Altern Med 2013; 13: 121.
3. Matsumoto K, Zhao Q, Niu Y, et al. Kampo formulations, chotosan, and yokukansan, for dementia therapy: existing clinical and preclinical evidence. J Pharmacol Sci 2013; 122: 257.
4. Iwasaki K, Kosaka K, Mori H, et al. Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine. Psychogeriatrics 2012; 12: 235.
5. Cui S, Sun Y, Liu C. Effect of bushenyisui formula on brain tissue apoptosis and Bcl-2 in beta-amyloid protein-induced Alzheimer's disease rat models. J Tradit Chin Med 2012; 32: 646.
6. Irie Y, Keung WM. Rhizoma acori graminei and its active principles protect PC-12 cells from the toxic effect of amyloid-beta peptide. Brain Res 2003; 963: 282.
7. Limon ID, Mendieta L, Diaz A, et al. Neuroprotective effect of alpha-asarone on spatial memory and nitric oxide levels in rats injected with amyloid-beta(25-35). Neurosci Lett 2009; 453: 98.
8. Kang M, Kim JH, Cho C, et al. Effect of Acori graminei Rhizoma on contractile dysfunction of ischemic and reperfused rat heart. Biol Pharm Bull 2006; 29: 483.
9. Lee B, Choi Y, Kim H, et al. Protective effects of methanol extract of Acori graminei rhizoma and Uncariae Ramulus et Uncus on ischemia-induced neuronal death and cognitive impairments in the rat. Life Sci 2003; 74: 435.
10. Mao QQ, Huang Z, Zhong XM, et al. Effects of SYJN, a Chinese herbal formula, on chronic unpredictable stress-induced changes in behavior and brain BDNF in rats. J Ethnopharmacol 2010; 128: 336.
11. Park SW, Kim YK, Lee JG, et al. Antidepressant-like effects of the traditional Chinese medicine kami-shoyo-san in rats. Psychiatry Clin Neurosci 2007; 61: 401.
12. Koo BS, Park KS, Ha JH, Park JH, Lim JC, Lee DU. Inhibitory effects of the fragrance inhalation of essential oil from Acorus gramineus on central nervous system. Biol Pharm Bull 2003; 26: 978.
13. Zheng M, Liu J, Ruan Z, et al. Intrahippocampal injection of Abeta1-42 inhibits neurogenesis and down-regulates IFN-gamma and NF-kappaB expression in hippocampus of adult mouse brain. Amyloid 2013; 20: 13.
14. Manabe T, Noda Y, Mamiya T, et al. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 1998; 394: 577.
15. Kobayashi K, Noda Y, Matsushita N, et al. Modest neuropsychological deficits caused by reduced noradrenaline metabolism in mice heterozygous for a mutated tyrosine hydroxylase gene. J Neurosci 2000; 20: 2418.
16. Takeda S, Sato N, Niisato K, et al. Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease. Brain Res 2009; 1280: 137.
17. Cho J, Kim YH, Kong JY, Yang CH, Park CG. Protection of cultured rat cortical neurons from excitotoxicity by asarone, a major essential oil component in the rhizomes of Acorus gramineus. Life Sci 2002; 71: 591.
18. Tang HM, Xi P, Wu M, Cai Q. Effects of Rhizoma Acori Tatarinowii on Amino Acids Neurotransmitter in Mice Brain 2004; 15: 310-11.
19. Chatani K, Kawakami M, Weinstein JN, Meller ST, Gebhart GF. Characterization of thermal hyperalgesia, c-fos expression, and alterations in neuropeptides after mechanical irritation of the dorsal root ganglion. Spine 1995; 20: 277-90.
20. Krupkova OJ, Loja T, Zambo I, Veselska R. Nestin expression in human tumors and tumor cell lines. Neoplasma 2010; 57: 291.
21. Li HY, Say EH, Zhou XF. Isolation and characterization of neural crest progenitors from adult dorsal root ganglia. Stem Cells 2007; 25: 2053.
22. Stephan A, Laroche S, Davis S. Generation of aggregated betaamyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci 2001; 21: 5703.
23. Prediger RD, Medeiros R, Pandolfo P, et al. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease. Neuroscience 2008; 151: 631.
24. Ryu JK, McLarnon JG. Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer's disease. Neuroreport 2008; 19: 1715.
25. Shankar GM, Walsh DM. Alzheimer's disease: synaptic dysfunction and Abeta. Mol Neurodegener 2009; 4: 48.
26. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366: 2112.
27. Hashimoto M, Shahdat HM, Yamashita S, et al. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats. J Neurochem 2008; 107: 1634.
28. Rao MS, Shetty AK. Efficacy of doublecortin as a marker to analyse the absolute number and dendritic growth of newly generated neurons in the adult dentate gyrus. Eur J Neurosci 2004; 19: 234.
29. Nomura S, Kami K, Kawano F, et al. Effects of hindlimb unloading on neurogenesis in the hippocampus of newly weaned rats. Neurosci Lett 2012; 509: 76.
30. Jin K, Peel AL, Mao XO, et al. Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci USA 2004; 101: 343.
31. Gilyarov AV. Nestin in central nervous system cells. Neurosci Behav Physiol 2008; 38: 165.
32. Saito S, Suzuki A, Nozawa-Inoue K, et al. Immunohistochemical detection of nestin in the periodontal Ruffini endings of the rat incisor. Neurosci Lett 2009; 449: 195.
33. Kamphuis W, Mamber C, Moeton M, et al. GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease. PLoS One 2012; 7: e42823.
34. Lin RC, Matesic DF, Marvin M, McKay RD, Brustle O. Reexpression of the intermediate filament nestin in reactive astrocytes. Neurobiol Dis 1995; 2: 79.